Long-Term Treatment Strategies of Pediatric Multiple Sclerosis, Including the use of Disease Modifying Therapies

by Mary Rensel
Published 2019-05-01

Safety of Newer Disease Modifying Therapies in Multiple Sclerosis

by Georges Jalkh, Rachelle Abi Nahed, Gabrielle Macaron, Mary Rensel
Published 2021-12-01

Gut microbiome is associated with multiple sclerosis activity in children

by Mary K. Horton, Kathryn McCauley, Douglas Fadrosh, Kei Fujimura, Jennifer Graves, Jayne Ness, Yolanda Wheeler, Mark P. Gorman, Leslie A. Benson, Bianca Weinstock‐Guttman, Amy Waldman, Moses Rodriguez, Jan‐Mendelt Tillema, Lauren Krupp, Anita Belman, Soe Mar, Mary Rensel, Tanuja Chitnis, Theron Charles Casper, John Rose, Janace Hart, Xiaorong Shao, Helen Tremlett, Susan V. Lynch, Lisa F. Barcellos, Emmanuelle Waubant, the U.S. Network of Pediatric MS Centers
Published 2021-09-01

Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.

by Calvin Chi, Xiaorong Shao, Brooke Rhead, Edlin Gonzales, Jessica B Smith, Anny H Xiang, Jennifer Graves, Amy Waldman, Timothy Lotze, Teri Schreiner, Bianca Weinstock-Guttman, Gregory Aaen, Jan-Mendelt Tillema, Jayne Ness, Meghan Candee, Lauren Krupp, Mark Gorman, Leslie Benson, Tanuja Chitnis, Soe Mar, Anita Belman, Theron Charles Casper, John Rose, Manikum Moodley, Mary Rensel, Moses Rodriguez, Benjamin Greenberg, Llana Kahn, Jennifer Rubin, Catherine Schaefer, Emmanuelle Waubant, Annette Langer-Gould, Lisa F Barcellos
Published 2019-01-01